drug

samuraciclib

1 story · latest Oct 27, 2026

Follow samuraciclib. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.

Follow free for 14 daysNo card.

Status: Investigational
Codes: CT7001, ICEC0942
Trials: 1 registered trial in coverage

Relationships

Developed by Roche

Timeline

Pfizer terminates TACTIVE-U Sub-Study C of vepdegestrant plus samuraciclib

Oct 27Trial updatePfizer Rigel Pharmaceuticals Inc

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.